Black Diamond Therapeutics, Inc. (BDTX): Capital Expenditures

Annual figures by period end, from SEC filings.

$0
Year ended 2024-12-31
$2.71M2018-12-31: $76.0K2019-12-31: $21.0K2020-12-31: $142.0K2021-12-31: $2.71M2022-12-31: $192.0K2023-12-31: $33.0K2024-12-31: $0$0
2018-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$0-100.0%2025-03-06, From 2024-01-01
2023-12-31$33.0K-82.8%2025-03-06, From 2023-01-01
2022-12-31$192.0K-92.9%2024-03-12, From 2022-01-01
2021-12-31$2.71Mn/m2023-03-09, From 2021-01-01
2020-12-31$142.0K+576.2%2022-03-17, From 2020-01-01
2019-12-31$21.0K-72.4%2021-03-25, From 2019-01-01
2018-12-31$76.0Kn/a2020-03-24, From 2018-01-01